Bioactivity:

MPT0E028 is an orally active and selective inhibitor of HDAC (IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2, and HDAC6, respectively). MPT0E028 has good anticancer activity. MPT0E028 decreases the viability of B-cell lymphomas by inducing apoptosis

CAS nr:

1338320-94-7

Purity:

98%

Molecular Weight:

344,38

SMILES:

O=C(/C=C/C1=CC2=C(C=C1)N(CC2)S(=O)(C3=CC=CC=C3)=O)NO

Formula:

C17H16N2O4S

Pathway:

Others

Target:

Others